Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Zelenitsky

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Canadian Journal of Hospital Pharmacy|December 1, 1993
Implementation of an aminoglycoside order review process in a central dispensaryS A Zelenitsky, A Richard
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 1993
Ketorolac (Toradol): a marketing phenomenonR E Ariano, S A Zelenitsky
The Annals of Pharmacotherapy|July 1, 1996
Phenazopyridine in urinary tract infectionsS A Zelenitsky, G G Zhanel
The Journal of Vascular Access|December 29, 2007
Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infectionsT A Takla, S A Zelenitsky, L M Vercaigne
Pharmacotherapy|May 1, 1997
Aminoglycoside adaptive resistanceJ A Karlowsky, S A Zelenitsky, G G Zhanel
The Journal of Hospital Infection|October 26, 2000
A prospective, randomized, double-blind studyof single high dose versus multiple standard dose gentamicin both in combination withmetronidazole for colorectal surgicalprophylaxisS A Zelenitsky, R E Silverman, H Duckworth, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1997
Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosaJ A Karlowsky, D J Hoban, S A Zelenitsky, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strainsS A Zelenitsky, J A Karlowsky, G G Zhanel, et al.
Chemotherapy|January 28, 1998
Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic modelS A Zelenitsky, J A Karlowsky, D J Hoban, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agentsG G Zhanel, J A Karlowsky, S A Zelenitsky, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Canadian Journal of Hospital Pharmacy|December 1, 1993
Implementation of an aminoglycoside order review process in a central dispensaryS A Zelenitsky, A Richard
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 1993
Ketorolac (Toradol): a marketing phenomenonR E Ariano, S A Zelenitsky
The Annals of Pharmacotherapy|July 1, 1996
Phenazopyridine in urinary tract infectionsS A Zelenitsky, G G Zhanel
The Journal of Vascular Access|December 29, 2007
Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infectionsT A Takla, S A Zelenitsky, L M Vercaigne
Pharmacotherapy|May 1, 1997
Aminoglycoside adaptive resistanceJ A Karlowsky, S A Zelenitsky, G G Zhanel
The Journal of Hospital Infection|October 26, 2000
A prospective, randomized, double-blind studyof single high dose versus multiple standard dose gentamicin both in combination withmetronidazole for colorectal surgicalprophylaxisS A Zelenitsky, R E Silverman, H Duckworth, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1997
Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosaJ A Karlowsky, D J Hoban, S A Zelenitsky, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strainsS A Zelenitsky, J A Karlowsky, G G Zhanel, et al.
Chemotherapy|January 28, 1998
Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic modelS A Zelenitsky, J A Karlowsky, D J Hoban, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agentsG G Zhanel, J A Karlowsky, S A Zelenitsky, et al.
Pageof 2